Arrowhead Historical Balance Sheet


USD 31.54  2.39  7.04%   

Trend analysis of Arrowhead Pharmaceuticals balance sheet accounts such as Accounts Payable of 9.2 M, Total Assets of 689.6 M or Current Assets of 373.5 M provides information on Arrowhead Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Arrowhead Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Arrowhead Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year. Financial Statement Analysis is much more than just reviewing and breaking down Arrowhead Pharmaceuticals prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Arrowhead Pharmaceuticals is a good buy for the upcoming year.
Please continue to Trending Equities.

About Arrowhead Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Arrowhead Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Arrowhead Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Arrowhead Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Arrowhead currently owns. An asset can also be divided into two categories, current and non-current.

Arrowhead Pharmaceuticals Balance Sheet Chart

Arrowhead Pharmaceuticals Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Arrowhead Pharmaceuticals uses and utilizes its capital. It also shows what exactly a company owns and owes.
Arrowhead Pharmaceuticals Debt Current is relatively stable at the moment as compared to the past year. Arrowhead Pharmaceuticals reported last year Debt Current of 2.59 Million. As of 12/05/2022, Debt Non Current is likely to grow to about 28.9 M, while Accumulated Other Comprehensive Income is likely to drop (67 K).

Total Assets

Total assets refers to the total amount of Arrowhead Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Arrowhead Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; Goodwill and Intangible Assets; Property Plant and Equipment Net; [TaxAssets] and Trade and Non Trade Receivables.

Current Assets

Current assets of Arrowhead Pharmaceuticals include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Arrowhead Pharmaceuticals. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Shareholders Equity

A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.

Total Liabilities

Deferred Income Tax is recorded on Arrowhead Pharmaceuticals balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Arrowhead Pharmaceuticals books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; Deferred Revenue; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.
Most accounts from Arrowhead Pharmaceuticals balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Arrowhead Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please continue to Trending Equities.Arrowhead Pharmaceuticals Debt Current is relatively stable at the moment as compared to the past year. Arrowhead Pharmaceuticals reported last year Debt Current of 2.59 Million. As of 12/05/2022, Debt Non Current is likely to grow to about 28.9 M, while Accumulated Other Comprehensive Income is likely to drop (67 K).
 2019 2020 2021 2022 (projected)
Accounts Payable6.83 M9.46 M8.51 M9.18 M
Receivables845.67 K10.26 M9.23 M9.96 M

Arrowhead Pharmaceuticals balance sheet Correlations

Click cells to compare fundamentals

Arrowhead Pharmaceuticals Account Relationship Matchups

Arrowhead Pharmaceuticals balance sheet Accounts

201720182019202020212022 (projected)
Receivables327.38 K661.36 K845.67 K10.26 M9.23 M9.96 M
Accounts Payable2.81 M7.65 M6.83 M9.46 M8.51 M9.18 M
Accumulated Other Comprehensive Income(21.56 K)(391.62 K)18 K(69 K)(62.1 K)(67 K)
Total Assets111.61 M349.85 M522.5 M710.15 M639.13 M689.59 M
Current Assets78.77 M265.25 M322.37 M384.6 M346.14 M373.46 M
Assets Non Current32.84 M84.6 M200.13 M325.55 M374.38 M403.94 M
Cash and Equivalents30.13 M221.8 M228.6 M311.16 M280.05 M302.15 M
Cash and Equivalents USD30.13 M221.8 M143.58 M184.43 M212.1 M228.84 M
Total Debt2.53 M2.33 M21.14 M25.55 M29.38 M31.7 M
Debt Current208.51 K223.82 K1.09 M2.25 M2.59 M2.79 M
Debt Non Current2.33 M2.1 M20.04 M23.3 M26.79 M28.9 M
Total Debt USD2.53 M2.33 M21.14 M25.55 M29.38 M31.7 M
Deferred Revenue60082.8 M19.29 M242.55 M278.93 M300.95 M
Shareholders Equity95.8 M244.59 M461.78 M408.82 M367.94 M396.99 M
Shareholders Equity USD95.8 M244.59 M461.78 M408.82 M470.15 M507.26 M
Goodwill and Intangible Assets18.76 M17.06 M15.36 M13.66 M15.71 M15.8 M
Investments46.4 M81.08 M309.4 M428.95 M493.29 M532.24 M
Investments Current46.4 M36.9 M171.91 M183.35 M210.86 M227.5 M
Total Liabilities15.81 M105.25 M60.72 M301.33 M271.19 M292.6 M
Current Liabilities12.36 M97.07 M40.68 M146.54 M131.88 M142.29 M
Liabilities Non Current4 M8.74 M20.04 M154.79 M178.01 M192.06 M
Trade and Non Trade Payables2.81 M7.65 M6.83 M9.46 M10.88 M11.73 M
Property Plant and Equipment Net13.94 M23.21 M47.02 M66.02 M75.92 M81.92 M
Trade and Non Trade Receivables327.38 K661.36 K846 K10.26 M11.79 M12.72 M
Accumulated Retained Earnings Deficit(487.27 M)(419.29 M)(503.84 M)(644.69 M)(580.22 M)(595.49 M)

Be your own money manager

Our tools can tell you how much better you can do entering a position in Arrowhead Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Analyzer Now


Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Pair Trading with Arrowhead Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arrowhead Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Arrowhead Pharmaceuticals

+0.63BEAMBeam TherapeuticsInc Normal TradingPairCorr
+0.76CPHIChina Pharma Holdings TrendingPairCorr
The ability to find closely correlated positions to Arrowhead Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arrowhead Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arrowhead Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arrowhead Pharmaceuticals to buy it.
The correlation of Arrowhead Pharmaceuticals is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arrowhead Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arrowhead Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arrowhead Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for analysis

When running Arrowhead Pharmaceuticals price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bond Directory
Find actively traded corporate debentures issued by US companies
CEO Directory
Screen CEOs from public companies around the world
CEO Directory
Screen CEOs from public companies around the world
CEO Directory
Screen CEOs from public companies around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Is Arrowhead Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.6 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Arrowhead Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.